Matthew Winton insider trades: CervoMed (CRVO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | CRVO | ↑ Buy | 5,000 | $8.29 | $41K | Direct | Nov 19, 2025 (1d) |
| Nov 14, 2025 | CRVO | ↑ Buy | 10,000 | $7.57 | $76K | Direct | Nov 17, 2025 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRVO insiders
Open-market trades in the last 12 months
About Matthew Winton's insider trades
Matthew Winton is Chief Commercial and Business at CervoMed (CRVO). Since Nov 14, 2025, Matthew has reported 2 open-market purchases worth $117K and no sales on SEC Form 4. In the last 12 months: 2 buys ($117K).
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRVO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.